Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Galenus GH (officially Galenus - G.H. (Gesundheit und Health Care) AG) is a Swiss contract research organization (CRO) headquartered in Hergiswil, Nidwalden. Founded in 2005, the company specializes in the execution, processing, and strategic planning of clinical studies worldwide. It provides a comprehensive suite of clinical trial management services, including clinical monitoring, investigator recruitment, medical expertise, project management, and regulatory services. Additionally, Galenus GH is involved in translational research and holds patents for therapeutic compositions, such as resveratrol-based formulations and sodium polyphosphate (Na-polyP) hydrogels for wound healing and atopic dermatitis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Galenus GH.